期刊
NATURE CLINICAL PRACTICE NEUROLOGY
卷 4, 期 2, 页码 106-111出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ncpneuro0706
关键词
epilepsy; glycogen metabolism; Lafora disease; polyglucosan bodies; progressive myoclonus
Background A 20-year-old woman presented to a specialist epilepsy center with a 3-year history of drug-resistant epileptic seizures, progressive myoclonus, ataxia, and cognitive decline. Investigations Neurological examination, neuropsychological testing, electrophysiological studies, skin biopsy, MRI, genetic testing, and autopsy. Diagnosis Lafora disease (EPM2), resulting from a homozygous missense mutation in EPM2B (NHLRC1; c205C>G; Pro69Ala). Management Symptomatic treatment with conventional antiepileptic and antimyoclonic drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据